[go: up one dir, main page]

SMT201800488T1 - Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Info

Publication number
SMT201800488T1
SMT201800488T1 SM20180488T SMT201800488T SMT201800488T1 SM T201800488 T1 SMT201800488 T1 SM T201800488T1 SM 20180488 T SM20180488 T SM 20180488T SM T201800488 T SMT201800488 T SM T201800488T SM T201800488 T1 SMT201800488 T1 SM T201800488T1
Authority
SM
San Marino
Prior art keywords
interleukin
antibodies
receptor
formulations containing
containing anti
Prior art date
Application number
SM20180488T
Other languages
Italian (it)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2011/054856 external-priority patent/WO2012047954A1/en
Publication of SMT201800488T1 publication Critical patent/SMT201800488T1/en

Links

SM20180488T 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies SMT201800488T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
EP11770625.9A EP2624865B1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
SMT201800488T1 true SMT201800488T1 (en) 2018-11-09

Family

ID=45995014

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20180488T SMT201800488T1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Country Status (14)

Country Link
AR (1) AR083338A1 (en)
DK (2) DK3354280T3 (en)
ES (2) ES2687813T3 (en)
HK (1) HK1258305A1 (en)
HR (1) HRP20181822T1 (en)
HU (1) HUE052089T2 (en)
LT (1) LT2624865T (en)
PT (1) PT3354280T (en)
RS (1) RS57850B1 (en)
SI (1) SI2624865T1 (en)
SM (1) SMT201800488T1 (en)
TW (7) TWI782325B (en)
UA (1) UA111731C2 (en)
UY (1) UY33652A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ631562A (en) 2012-08-21 2017-03-31 Regeneron Pharma Methods for treating or preventing asthma by administering an il-4r antagonist
NZ631118A (en) * 2013-06-21 2019-05-31 Regeneron Pharma Methods for treating nasal polyposis by administering an il-4r antagonist
RS59354B1 (en) * 2013-06-21 2019-10-31 Sanofi Biotechnology Methods for treating nasal polyposis by administering an il-4r antagonist
EP3218412A1 (en) 2014-11-14 2017-09-20 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
KR102785099B1 (en) 2017-10-30 2025-03-26 사노피 바이오테크놀로지 Methods for treating or preventing asthma by administering an il-4r antagonist

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (en) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% PATTERN ALIGNMENT SYSTEM IN A SUBSTRATE BY LITOGRAPHY BY ESTENCIL.
WO2010029664A1 (en) * 2008-09-10 2010-03-18 日本エクスラン工業株式会社 Crosslinked acrylate-based fibers and the production thereof
KR20110128333A (en) * 2009-03-06 2011-11-29 제넨테크, 인크. Antibody Formulations

Also Published As

Publication number Publication date
TWI568445B (en) 2017-02-01
TWI690329B (en) 2020-04-11
TW202320851A (en) 2023-06-01
TW201924718A (en) 2019-07-01
TWI782325B (en) 2022-11-01
TW201542229A (en) 2015-11-16
TW201716086A (en) 2017-05-16
HK1258305A1 (en) 2019-11-08
TWI856388B (en) 2024-09-21
TWI679988B (en) 2019-12-21
TWI718890B (en) 2021-02-11
RS57850B1 (en) 2018-12-31
UA111731C2 (en) 2016-06-10
UY33652A (en) 2012-04-30
TWI498121B (en) 2015-09-01
DK3354280T3 (en) 2020-09-28
DK2624865T3 (en) 2018-10-22
HUE052089T2 (en) 2021-04-28
TW202102262A (en) 2021-01-16
ES2687813T3 (en) 2018-10-29
LT2624865T (en) 2018-10-25
AR083338A1 (en) 2013-02-21
TW201221141A (en) 2012-06-01
PT3354280T (en) 2020-09-01
TW202026011A (en) 2020-07-16
SI2624865T1 (en) 2018-10-30
HRP20181822T1 (en) 2018-12-28
ES2820246T3 (en) 2021-04-20

Similar Documents

Publication Publication Date Title
IL283424A (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
HRP20181821T1 (en) Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies
IL265501B (en) Stabilized antibody-containing liquid formulations
SI3409289T1 (en) Stable antibody containing compositions
HK1258305A1 (en) Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies
EP2588141A4 (en) Antibody formulations